Earlier studies suggest that GPR4 supports inflammation; we therefore hypothesized that inflammation and spontaneous tumor development would be reduced in the AOM/DSS model of colitis‐induced cancer in Gpr4‐deficient animals. Here, GPR4 is linked to cancer.